Variant report
Variant | nsv582226 |
---|---|
Chromosome Location | chr2:76605834-76619579 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:76615182..76615716-chr4:38819540..38820084,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs908957 | chr2:76605834-76605835 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs577560218 | chr2:76605846-76605847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545127607 | chr2:76605956-76605957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559950041 | chr2:76605966-76605967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148858521 | chr2:76605967-76605968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs908958 | chr2:76605991-76605992 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs143484261 | chr2:76606038-76606039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11898958 | chr2:76606050-76606051 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs78466445 | chr2:76606068-76606069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs908959 | chr2:76606093-76606094 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs189282417 | chr2:76606095-76606096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551857019 | chr2:76606101-76606102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368482248 | chr2:76606129-76606130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147986088 | chr2:76606131-76606132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533755288 | chr2:76606132-76606133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548802640 | chr2:76606142-76606143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs115343792 | chr2:76606156-76606157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs114348694 | chr2:76607218-76607219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149382601 | chr2:76607248-76607249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186340715 | chr2:76607283-76607284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551553222 | chr2:76607320-76607321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375682159 | chr2:76607336-76607337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558113351 | chr2:76607369-76607370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556834058 | chr2:76607380-76607381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs578213929 | chr2:76607412-76607413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144713404 | chr2:76607420-76607421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148509170 | chr2:76607477-76607478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527666803 | chr2:76607533-76607534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114834085 | chr2:76607569-76607570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560999147 | chr2:76607584-76607585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531422529 | chr2:76607593-76607594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145395829 | chr2:76607607-76607608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571403254 | chr2:76607618-76607619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147665160 | chr2:76607697-76607698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141056259 | chr2:76607723-76607724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs144908251 | chr2:76607731-76607732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536207645 | chr2:76607734-76607735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191102599 | chr2:76607752-76607753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs151306716 | chr2:76607754-76607755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140534180 | chr2:76607771-76607772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533742173 | chr2:76607794-76607795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556510533 | chr2:76607799-76607800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs578123898 | chr2:76607801-76607802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545420583 | chr2:76607826-76607827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554000295 | chr2:76607847-76607848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571431244 | chr2:76607885-76607886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572108502 | chr2:76607904-76607905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79639684 | chr2:76607996-76607997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561060275 | chr2:76608015-76608016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576162293 | chr2:76608048-76608049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76605800-76606200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:76607200-76609200 | Enhancers | Fetal Heart | heart |
3 | chr2:76613000-76613600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:76618200-76619800 | Enhancers | Fetal Heart | heart |
5 | chr2:76618400-76619200 | Enhancers | Duodenum Mucosa | Duodenum |
6 | chr2:76618400-76619400 | Enhancers | HepG2 | liver |
7 | chr2:76618600-76619200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr2:76618600-76619200 | Enhancers | Small Intestine | intestine |
9 | chr2:76618600-76619200 | Enhancers | Stomach Mucosa | stomach |
10 | chr2:76618600-76619400 | Enhancers | Fetal Intestine Small | intestine |
11 | chr2:76618800-76619400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
12 | chr2:76619200-76624400 | Weak transcription | Duodenum Mucosa | Duodenum |
13 | chr2:76619400-76624200 | Weak transcription | Fetal Intestine Small | intestine |